Seroprevalence of Leptospira spp. in Horses in Israel

Sharon Tirosh-Levy, Miri Baum, Gili Schvartz, Boaz Kalir, Oren Pe’er, Anat Shnaiderman‐Torban, Michael S. Bernstein, Shlomo E. Blum, Amir SteinmanPathogens 2021 · DOI

TL;DR

This study reports the first identification of Leptospira serogroup Pomona as a likely cause of Equine Recurrent Uveitis (ERU) in horses in Israel. An epidemiological investigation revealed a higher prevalence of Leptospira exposure in horses during a period of known outbreaks in other species, highlighting a potential zoonotic risk to humans.

What Problem Does This Paper Address?

Leptospirosis, a zoonotic disease caused by Leptospira bacteria, is well-documented in humans and various animal species globally and in Israel. However, its presence and impact on horses in Israel had not been previously reported. While Leptospira is known to cause Equine Recurrent Uveitis (ERU) in horses elsewhere, its role in Israeli equine health was unclear. This paper addresses this knowledge gap by investigating the seroprevalence of Leptospira in Israeli horses, particularly in relation to ERU, and exploring potential sources of infection, especially in the context of concurrent outbreaks in other animal populations.

Methods

The study employed a serological approach using the microscopic agglutination test (MAT) to detect antibodies against Leptospira in horse serum samples. This is a standard method for diagnosing past exposure to Leptospira. The MAT was performed using antigens from eight different Leptospira serovars, with a particular focus on serogroup Pomona. The researchers collected serum samples from horses at different time points:

  • Initial Case Investigation: Serum from a mare with suspected ERU was tested.
  • Farm-Specific Investigation: Horses from the mare's farm (Farm 1) were sampled in 2017 and again in 2018.
  • Broader Epidemiological Survey: Sera from horses across multiple farms in Israel were analyzed from samples collected in 2015, 2017, and 2018.

The study also involved quarantine measures and antibiotic treatment (enrofloxacin) for horses on the affected farm.

Datasets

The study utilized existing serum samples from horses collected at three different time points:

  • 2015: 259 horses from 21 farms across Israel.
  • 2017: 70 horses from three farms, including two in the Carmel area.
  • 2018: 337 horses from 29 farms across Israel.

These datasets represent a significant sampling effort to assess the geographical and temporal distribution of Leptospira exposure in the Israeli equine population.

Key Insights and Ideas

  • First Evidence of Leptospira in Israeli Horses: This study provides the initial documented evidence of Leptospira exposure in horses in Israel, specifically linking serogroup Pomona to ERU cases.
  • Temporal Correlation with Outbreaks: The increased seroprevalence of Leptospira serogroup Pomona in horses in 2017 coincided with reported outbreaks of this serogroup in humans and cattle in Israel, suggesting that horses may be exposed during broader epizootic events.
  • Zoonotic Risk Highlighted: The identification of Leptospira in stabled horses, particularly those in close proximity to cattle and wild animals, raises concerns about potential zoonotic transmission to humans, especially given the known outbreaks in the region.
  • ERU as a Key Indicator: The study reinforces the established link between Leptospira infection and ERU in horses, suggesting that ERU in Israel should prompt consideration of leptospirosis in the differential diagnosis.

Key Results

  • In 2017, seven out of thirteen horses on Farm 1 tested seropositive for Leptospira serogroup Pomona, with three of these also exhibiting signs of ERU.
  • During the same period in 2017, 14 out of 70 horses from three other farms were positive for serogroup Pomona.
  • In contrast, in 2015, only one horse out of 259 tested seropositive for Leptospira serovar Icterohaemorrhagiae, and none were positive for serogroup Pomona.
  • In 2018, a survey of 337 horses from 29 farms found no seropositive cases for serogroup Pomona.
  • Horses on Farm 1 that were seropositive in 2017 remained seropositive in 2018, though with lower or similar antibody titers, indicating persistent exposure or immunity.

Limitations and Future Work

  • Lack of Direct Pathogen Detection: The study relied solely on serological evidence (MAT), which indicates past exposure but does not isolate or directly identify the bacteria. Future work should focus on pathogen detection through PCR or bacterial culture to confirm the presence of specific Leptospira strains and genotypes in Israel.
  • Limited Understanding of Transmission Dynamics: While the study suggests potential sources of infection (cattle, wild animals), the precise transmission routes and environmental factors contributing to Leptospira spread in horses require further investigation.
  • Unknown Serovar Prevalence in 2015: The 2015 survey primarily focused on serovar Icterohaemorrhagiae, with limited data on other serovars, making a direct comparison of overall Leptospira prevalence across all serovars challenging for that year.
  • Future Surveillance: Continued surveillance is recommended to monitor the presence and spread of Leptospira in the equine population. The authors also suggest investigating the impact of potential compulsory vaccination of beef cattle on reducing environmental contamination.

Summary updated

Abstract

Leptospirosis has been reported in both humans and animals in Israel but has not been reported in horses. In 2018, an outbreak of <i>Leptospira</i> spp. serogroup Pomona was reported in humans and cattle in Israel. In horses, leptospirosis may cause equine recurrent uveitis (ERU). This report describes the first identification of <i>Leptospira</i> serogroup Pomona as the probable cause of ERU in horses in Israel, followed by an epidemiological investigation of equine exposure in the area. Serologic exposure to <i>Leptospira</i> was determined by microscopic agglutination test (MAT) using eight serovars. In 2017, serovar Pomona was identified in a mare with signs of ERU. Seven of thirteen horses from that farm were seropositive for serogroup Pomona, of which three had signs of ERU. During the same time period, 14/70 horses from three other farms were positive for serogroup Pomona. In 2015, two years prior to this diagnosis, 259 horses from 21 farms were sampled and one horse tested seropositive for serovar Icterohaemorrhagiae. In 2018, one year later, 337 horses were sampled on 29 farms, with none testing seropositive. Although horses are not considered a major host of <i>Leptospira</i> spp., it appears that horses may be infected, and clinically affected, in the course of an outbreak in other species. The identification of leptospirosis in stabled horses may impose a significant zoonotic risk to people.
BibTeX
@inproceedings{tiroshlevy2021seroprevalence,
  author = {Sharon Tirosh-Levy and Miri Baum and Gili Schvartz and Boaz Kalir and Oren Pe’er and Anat Shnaiderman‐Torban and Michael S. Bernstein and Shlomo E. Blum and Amir Steinman},
  title = {{Seroprevalence of Leptospira spp. in Horses in Israel}},
  booktitle = {Pathogens},
  year = {2021},
  doi = {10.3390/pathogens10040408},
}
Figure